Systemic therapy for sarcoidosis is reserved for organ-threatening disease, and laryngeal involvement necessitates treatment ...
ETX-19477 is a potent, selective inhibitor of poly (ADP-ribose) glycohydrolase (PARG), an enzyme that plays a role in the DNA ...
Intrapleural enzyme therapy (IET) improves outcomes in adult inpatients with complicated parapneumonic pleural effusion or empyema.
SaveHealth reports on eczema medications, detailing various options from topical treatments to advanced therapies for ...
Fluoride remains the cornerstone of preventive dentistry, and researchers have analyzed the many delivery methods of fluoride treatment.
Both Phase 3 trials met all primary and secondary endpoints with high statistical significance in patients with moderate-to-severe plaque ...
Biosplice Therapeutics, Inc. (“Biosplice”), a clinical-stage biotechnology company pioneering first-in-class therapeutics based on small-molecule inhibition of CLK/DYRK kinases, announced today that ...
The progress in understanding the pathophysiology of hidradenitis suppurativa appears to be leading to treatment strategies ...
Some clinicians are embracing transparency in response to patients’ questions about products hyped on social media; others ...
A 29-year-old woman was referred to Tufts Medical Center for undifferentiated bilateral anterior and intermediate uveitis.The ...
Gordian Bio, a biotechnology company pioneering large-scale in vivo functional genomics to unlock validated drug targets for ...
A research team provides an overview of how engineered probiotics—genetically modified beneficial microbes—are being transformed into living medicines capable of sensing disease, delivering therapies, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback